[{"address1": "4149 Liberty Canyon Road", "city": "Agoura Hills", "state": "CA", "zip": "91301", "country": "United States", "phone": "805 730 0360", "website": "https://www.acelyrin.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease. In addition, the company's develops SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California.", "fullTimeEmployees": 83, "companyOfficers": [{"maxAge": 1, "name": "Ms. Mina  Kim J.D.", "age": 50, "title": "CEO & Director", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tyler  Marciniak", "title": "Vice President of Investor Relations, Communications & Corporate Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. K. Amar Murugan J.D.", "age": 48, "title": "Chief Legal Officer", "yearBorn": 1976, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  Chow", "title": "Chief People Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kenneth A. Lock", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Patricia A. Turney", "age": 57, "title": "Chief Technical Operations Officer", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1740787200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.77, "open": 2.74, "dayLow": 2.704, "dayHigh": 2.84, "regularMarketPreviousClose": 2.77, "regularMarketOpen": 2.74, "regularMarketDayLow": 2.704, "regularMarketDayHigh": 2.84, "payoutRatio": 0.0, "forwardPE": -1.2971699, "volume": 1292828, "regularMarketVolume": 1292828, "averageVolume": 2198653, "averageVolume10days": 946380, "averageDailyVolume10Day": 946380, "bid": 2.01, "ask": 3.5, "bidSize": 2, "askSize": 2, "marketCap": 276952512, "fiftyTwoWeekLow": 1.845, "fiftyTwoWeekHigh": 7.3, "fiftyDayAverage": 2.2889, "twoHundredDayAverage": 4.2198, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -163623904, "profitMargins": 0.0, "floatShares": 72438583, "sharesOutstanding": 100710000, "sharesShort": 4301951, "sharesShortPriorMonth": 5868409, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0429, "heldPercentInsiders": 0.088190004, "heldPercentInstitutions": 1.05688, "shortRatio": 1.27, "shortPercentOfFloat": 0.048899997, "impliedSharesOutstanding": 100710000, "bookValue": 4.562, "priceToBook": 0.6028058, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -248226000, "trailingEps": -2.5, "forwardEps": -2.12, "enterpriseToEbitda": 0.558, "52WeekChange": -0.5919881, "SandP52WeekChange": 0.086116076, "quoteType": "EQUITY", "currentPrice": 2.75, "targetHighPrice": 8.0, "targetLowPrice": 8.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 447880000, "totalCashPerShare": 4.447, "ebitda": -293040992, "totalDebt": 7304000, "quickRatio": 17.076, "currentRatio": 18.097, "debtToEquity": 1.594, "returnOnAssets": -0.29731, "returnOnEquity": -0.4454, "freeCashflow": -216692000, "operatingCashflow": -303920992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLRN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "ACELYRIN, INC.", "longName": "Acelyrin, Inc.", "regularMarketChangePercent": -0.722021, "regularMarketPrice": 2.75, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1742591265, "regularMarketTime": 1742587200, "exchange": "NMS", "messageBoardId": "finmb_698766339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1683207000000, "postMarketChangePercent": -1.44727, "postMarketPrice": 2.7102, "postMarketChange": -0.0397999, "regularMarketChange": -0.01999998, "regularMarketDayRange": "2.704 - 2.84", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2198653, "fiftyTwoWeekLowChange": 0.905, "fiftyTwoWeekLowChangePercent": 0.49051487, "fiftyTwoWeekRange": "1.845 - 7.3", "fiftyTwoWeekHighChange": -4.55, "fiftyTwoWeekHighChangePercent": -0.6232877, "fiftyTwoWeekChangePercent": -59.198807, "earningsTimestamp": 1742500800, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747771200, "earningsCallTimestampStart": 1731533400, "earningsCallTimestampEnd": 1731533400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.5, "epsForward": -2.12, "epsCurrentYear": -2.4, "priceEpsCurrentYear": -1.1458333, "fiftyDayAverageChange": 0.4611001, "fiftyDayAverageChangePercent": 0.20145053, "twoHundredDayAverageChange": -1.4698, "twoHundredDayAverageChangePercent": -0.34831035, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-05-05", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "displayName": "Acelyrin", "trailingPegRatio": null, "__fetch_time": "2025-03-22"}]